MX348079B - Formulacion de isoxazolina topica localizada que comprende glucofurol. - Google Patents

Formulacion de isoxazolina topica localizada que comprende glucofurol.

Info

Publication number
MX348079B
MX348079B MX2013007501A MX2013007501A MX348079B MX 348079 B MX348079 B MX 348079B MX 2013007501 A MX2013007501 A MX 2013007501A MX 2013007501 A MX2013007501 A MX 2013007501A MX 348079 B MX348079 B MX 348079B
Authority
MX
Mexico
Prior art keywords
glucofurol
isoxazoline
topic
localized
formulation
Prior art date
Application number
MX2013007501A
Other languages
English (en)
Spanish (es)
Other versions
MX2013007501A (es
Inventor
Stefan Fuchs
Anja Regina Heckeroth
Ramona Müller
Heike Williams
Hartmut Zoller
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43920659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX348079(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2013007501A publication Critical patent/MX2013007501A/es
Publication of MX348079B publication Critical patent/MX348079B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2013007501A 2010-12-27 2011-12-22 Formulacion de isoxazolina topica localizada que comprende glucofurol. MX348079B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10197090 2010-12-27
US201161430241P 2011-01-06 2011-01-06
PCT/EP2011/073830 WO2012089623A1 (en) 2010-12-27 2011-12-22 Topical localized isoxazoline formulation comprising glycofurol

Publications (2)

Publication Number Publication Date
MX2013007501A MX2013007501A (es) 2013-08-01
MX348079B true MX348079B (es) 2017-05-25

Family

ID=43920659

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013007501A MX348079B (es) 2010-12-27 2011-12-22 Formulacion de isoxazolina topica localizada que comprende glucofurol.
MX2019011837A MX390508B (es) 2010-12-27 2011-12-22 Formulación de isoxazolina tópica localizada que comprende glicofurol.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019011837A MX390508B (es) 2010-12-27 2011-12-22 Formulación de isoxazolina tópica localizada que comprende glicofurol.

Country Status (18)

Country Link
US (2) US20130274302A1 (cg-RX-API-DMAC7.html)
EP (1) EP2658541B2 (cg-RX-API-DMAC7.html)
JP (3) JP2014506249A (cg-RX-API-DMAC7.html)
KR (2) KR101992589B1 (cg-RX-API-DMAC7.html)
CN (2) CN108125951A (cg-RX-API-DMAC7.html)
AU (1) AU2011351579B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013015498A2 (cg-RX-API-DMAC7.html)
CA (1) CA2822853C (cg-RX-API-DMAC7.html)
DK (1) DK2658541T3 (cg-RX-API-DMAC7.html)
ES (1) ES2908254T3 (cg-RX-API-DMAC7.html)
HU (1) HUE058290T2 (cg-RX-API-DMAC7.html)
MX (2) MX348079B (cg-RX-API-DMAC7.html)
NZ (1) NZ611474A (cg-RX-API-DMAC7.html)
PL (1) PL2658541T3 (cg-RX-API-DMAC7.html)
PT (1) PT2658541T (cg-RX-API-DMAC7.html)
RU (1) RU2602189C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012089623A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201304515B (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ611476A (en) 2010-12-27 2015-10-30 Intervet Int Bv Topical localized isoxazoline formulation
MX348079B (es) * 2010-12-27 2017-05-25 Intervet Int Bv Formulacion de isoxazolina topica localizada que comprende glucofurol.
AR087838A1 (es) 2011-09-12 2014-04-23 Merial Ltd Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus metodos y usos
NZ731588A (en) 2012-02-06 2018-11-30 Boehringer Ingelheim Animal Health Usa Inc Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
PE20142279A1 (es) * 2012-03-13 2015-01-25 Bayer New Zealand Ltd Composiciones de accion prolongada
EP3733664A1 (en) 2013-11-01 2020-11-04 Boehringer Ingelheim Animal Health USA Inc. Antiparisitic and pesticidal isoxazoline compounds
EP2875726A1 (fr) * 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
HUE072822T2 (hu) 2013-12-20 2025-12-28 Intervet Int B V Izoxazolin kompozíciók és azok felhasználása parazita fertõzések megelõzésében vagy kezelésében állatokban
PL3878281T3 (pl) 2013-12-20 2023-07-31 Intervet International B.V. Zastosowanie związków izoksazoliny u drobiu
EP3131398B1 (en) 2014-04-17 2019-10-23 Boehringer Ingelheim Animal Health USA Inc. Use of malononitrile compounds for protecting animals from parasites
PL4008329T3 (pl) 2014-12-22 2025-11-17 Intervet International B.V. Związki izoksazoliny do zastosowania w leczeniu demodekozy
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
KR102593069B1 (ko) 2015-04-08 2023-10-23 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 이속사졸린 활성제를 포함하는 서방형 주사 제형, 이의 방법 및 용도
DK3298027T3 (da) 2015-05-20 2021-08-09 Boehringer Ingelheim Animal Health Usa Inc Anthelmintiske depsipeptidforbindelser
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
BR112019007605A2 (pt) 2016-10-14 2019-09-17 Boehringer Ingelheim Animal Health Usa Inc compostos pesticidas e parasiticidas de vinil isoxazolina
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
JP2020530850A (ja) 2017-08-14 2020-10-29 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 殺有害生物および殺寄生生物ピラゾール−イソキサゾリン化合物
BR112020010291A2 (pt) * 2017-11-23 2020-11-17 Ceva Sante Animale composição contendo moxidectina para tratamento de infestações de parasitas
AR113997A1 (es) 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
KR102785432B1 (ko) 2018-07-09 2025-03-21 베링거잉겔하임베트메디카게엠베하 구충성 헤테로시클릭 화합물
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
CN113825543B (zh) 2019-03-19 2024-09-06 勃林格殷格翰动物保健有限公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
KR20220004158A (ko) * 2019-05-03 2022-01-11 인터벳 인터내셔널 비.브이. 주사가능한 제약 조성물 및 그의 용도
WO2021010843A1 (en) 2019-07-16 2021-01-21 Donaghys Limited Transdermal solvent system and methods of use
US12497370B2 (en) 2019-12-18 2025-12-16 Elanco Tiergesundheit Ag Isoxazoline derivatives
AU2021278871A1 (en) 2020-05-28 2023-01-19 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물
CA3185969A1 (en) 2020-07-24 2022-01-27 Jean Marie Defauw Process for making an isoxazoline compound and intermediate thereof
WO2022140728A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animam Health Usa Inc. Parasiticidal collar comprising isoxazoline compounds
BR112023015168A2 (pt) 2021-01-27 2023-10-03 Corteva Agriscience Llc Compostos de ciclopropilamida contra parasitas em peixes
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
US12258193B2 (en) 2022-02-17 2025-03-25 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
NO20240925A1 (en) 2023-09-15 2025-03-17 Evah Atlantic Inc Dihydroisoxazole compound for use in reducing ectoparasite infestations on fish
WO2025191150A2 (en) 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
GB8331037D0 (en) * 1983-11-21 1983-12-29 May & Baker Ltd Compositions of matter
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US20050192319A1 (en) 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
AU2004228041B2 (en) * 2003-04-04 2009-06-04 Boehringer Ingelheim Animal Health USA Inc. Topical anthelmintic veterinary formulations
KR101137785B1 (ko) * 2003-07-18 2012-04-25 백스터 인터내셔널 인코포레이티드 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2182945T3 (en) 2007-06-27 2015-11-16 Du Pont PROCEDURE TO COMBAT PESTS WITH ANIMALS
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
FR2925337B1 (fr) * 2007-12-21 2010-01-15 Virbac Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
RU2518462C2 (ru) 2008-12-19 2014-06-10 Новартис Аг Органические соединения
WO2010128095A1 (en) 2009-05-07 2010-11-11 Novartis Ag Ectoparasiticidal compositions
EP3560923B1 (en) 2009-12-17 2021-05-05 Boehringer Ingelheim Animal Health USA Inc. Anti parasitic dihydroazole compounds and compositions comprising same
DK178277B1 (da) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
MX348079B (es) * 2010-12-27 2017-05-25 Intervet Int Bv Formulacion de isoxazolina topica localizada que comprende glucofurol.
NZ611476A (en) * 2010-12-27 2015-10-30 Intervet Int Bv Topical localized isoxazoline formulation
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Also Published As

Publication number Publication date
BR112013015498A2 (pt) 2016-11-01
KR20180125618A (ko) 2018-11-23
JP6357508B2 (ja) 2018-07-11
CN108125951A (zh) 2018-06-08
MX2019011837A (es) 2019-11-21
CA2822853C (en) 2021-05-11
WO2012089623A1 (en) 2012-07-05
CA2822853A1 (en) 2012-07-05
ES2908254T3 (es) 2022-04-28
CN103260620A (zh) 2013-08-21
EP2658541B2 (en) 2025-12-17
AU2011351579A1 (en) 2013-06-20
US20130274302A1 (en) 2013-10-17
RU2013135415A (ru) 2015-02-10
JP2018154657A (ja) 2018-10-04
RU2602189C2 (ru) 2016-11-10
EP2658541B1 (en) 2022-01-26
US20150011596A1 (en) 2015-01-08
KR101992589B1 (ko) 2019-06-24
KR20130130762A (ko) 2013-12-02
MX390508B (es) 2025-03-20
KR101920476B1 (ko) 2018-11-21
JP2016216489A (ja) 2016-12-22
EP2658541A1 (en) 2013-11-06
JP6539384B2 (ja) 2019-07-03
DK2658541T3 (da) 2022-04-04
AU2011351579B2 (en) 2016-04-21
PT2658541T (pt) 2022-03-11
ZA201304515B (en) 2014-03-26
MX2013007501A (es) 2013-08-01
JP2014506249A (ja) 2014-03-13
HUE058290T2 (hu) 2022-07-28
NZ611474A (en) 2015-08-28
PL2658541T3 (pl) 2022-04-04

Similar Documents

Publication Publication Date Title
MX348079B (es) Formulacion de isoxazolina topica localizada que comprende glucofurol.
MX383895B (es) Formulacion de isoxazolina topica localizada.
IL249830A0 (en) Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
MX2011008204A (es) Metodos para reducir la proliferacion y viabilidad de los agentes microbianos.
MX2019012979A (es) Composiciones para el cuidado bucal.
ECSP11010818A (es) Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
CR10444A (es) Anticuerpo humanizado de c-kit
WO2012076293A9 (de) Zubereitungen enthaltend polysiloxane mit stickstoffhaltigen gruppen
MX2013008647A (es) Metodo, composiciones y empaque para limpieza del intestino.
AR060165A1 (es) Proteina de suero como vehiculo de entrega para un agente activo
CL2014000450A1 (es) Compuestos derivados de n-(heteroarilmetil)-6-[(2-heteroarilciclopropil)metoxi]pririmidin-4-amina, inhibidores de pde10; composicion farmaceutica; y su uso para el tratamiento de un trastorno seleccionado de trastornos psicóticos, delirantes, entre otros.
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
MX2018015132A (es) Composiciones para el cuidado bucal.
WO2012106427A3 (en) Methods for treating diabetic foot ulcers
CL2012003543A1 (es) Mezcla herbicida sinergistica que comprende propizamida y aminopiralida; metodo para el control de la vegetacion indeseable que comprende aplicar la mezcla antes dicha.
CL2011000722A1 (es) Composicion farmaceutica en forma de unguento estable al almacenamiento, que comprende: a) un compuesto de vitamina d, b) un corticosteroide y c) un compuesto alquilamino sustituido, en un vehiculo de petrolato que opcionalmente contiene aceite mineral, tocoferol o una combinacion de ellos; uso en tratamiento de la psoriasis.
MX2016000116A (es) Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana.
WO2014023392A8 (en) Organic semiconducting formulation
BR112012017540A2 (pt) formulações antiparasitárias tópicas
IT1400808B1 (it) Estratti da vinaccioli, metodo di preparazione e uso degli stessi per il trattamento di vini.
WO2012174164A3 (en) Agonists of gpr131 and uses thereof
NZ745636A (en) Topical parasiticidal formulation
WO2014028780A3 (en) Antifungal compounds and methods of use
CR20110063A (es) Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de enfermedades fúngicas

Legal Events

Date Code Title Description
FG Grant or registration